December 13, 2011 Amorfix Announces Private Placement
November 17, 2011 Amorfix Will Develop A Diagnostic Test And Complete Its ALS Disease Management Product Portfolio
November 14, 2011 Amorfix Announces Second Quarter Fiscal 2012 Results
November 11, 2011 Amorfix And Helix Biopharma Partnering To Develop Targeted Cancer Therapeutics
September 30, 2011 Amorfix Provides Update on Alzheimer's Disease Diagnostic Program
September 26, 2011 Amorfix Misfolded SOD1 Therapeutic Programs at The Forefront of Major ALS Disease Discovery
September 13, 2011 Amorfix Announces First Quarter Fiscal 2012 Results
September 9, 2011 Amorfix Appoints Ms. Meryl J. Chertoff To Its Board Of Directors
August 29, 2011 Pan-Provincial Vaccine Enterprise Inc. using Amorfix technology (ProMIS) for vaccines against misfolded prion disease including TSEs and cancer
August 11, 2011 Amorfix Update On Preclinical Cancer Antibody
July 18, 2011 Amorfix Presents Preliminary Data From Human Diagnostic Test For Alzheimer's Disease at ICAD
June 29, 2011 Amorfix Announces Fiscal 2011 Year End Results
May 13, 2011 Amorfix Announces New Patents Awarded For Misfolded DOD1 Targets
March 11, 2011 Amorfix Announces Private Placement Offering
March 9, 2011 Amorfix To Present Data On Its Preclinical Assay For The Detection of Aggregated ABeta In CSF at International Conference On Alzheimer's and Parkinson's Diseases
February 24, 2011 Amorfix Life Sciences to Present at BioPartnering North America
February 14, 2011 Amorfix Announces Third Quarter Fiscal 2011 Results and $0.51 Million Private Placement
January 7, 2011 Amorfix Alzheimer's Test Detects Aggregated Beta Amyloid in Human CSF
January 4, 2011 Amorfix Announces Presentation and Webcast at the Biotech Showcase 2011 Conference